94 related articles for article (PubMed ID: 22926517)
21. Oncogenic role of miR-483-3p at the IGF2/483 locus.
Veronese A; Lupini L; Consiglio J; Visone R; Ferracin M; Fornari F; Zanesi N; Alder H; D'Elia G; Gramantieri L; Bolondi L; Lanza G; Querzoli P; Angioni A; Croce CM; Negrini M
Cancer Res; 2010 Apr; 70(8):3140-9. PubMed ID: 20388800
[TBL] [Abstract][Full Text] [Related]
22. Mutations in microRNA processing genes in Wilms tumors derepress the
Chen KS; Stroup EK; Budhipramono A; Rakheja D; Nichols-Vinueza D; Xu L; Stuart SH; Shukla AA; Fraire C; Mendell JT; Amatruda JF
Genes Dev; 2018 Aug; 32(15-16):996-1007. PubMed ID: 30026293
[TBL] [Abstract][Full Text] [Related]
23. Small Molecule Inhibition of miR-544 Biogenesis Disrupts Adaptive Responses to Hypoxia by Modulating ATM-mTOR Signaling.
Haga CL; Velagapudi SP; Strivelli JR; Yang WY; Disney MD; Phinney DG
ACS Chem Biol; 2015 Oct; 10(10):2267-76. PubMed ID: 26181590
[TBL] [Abstract][Full Text] [Related]
24. Pericyte-secreted IGF2 promotes breast cancer brain metastasis formation.
Molnár K; Mészáros Á; Fazakas C; Kozma M; Győri F; Reisz Z; Tiszlavicz L; Farkas AE; Nyúl-Tóth Á; Haskó J; Krizbai IA; Wilhelm I
Mol Oncol; 2020 Sep; 14(9):2040-2057. PubMed ID: 32534480
[TBL] [Abstract][Full Text] [Related]
25. CD44
Liu Y; Yu C; Wu Y; Sun X; Su Q; You C; Xin H
J Cell Mol Med; 2017 Sep; 21(9):1979-1988. PubMed ID: 28523716
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous screening of overexpressed genes in breast cancer for oncogenic drivers and tumor dependencies.
Mofunanya A; Cameron ER; Braun CJ; Celeste F; Zhao X; Hemann MT; Scott KL; Li J; Powers S
Sci Rep; 2024 Jun; 14(1):13227. PubMed ID: 38851782
[TBL] [Abstract][Full Text] [Related]
27. IGF2 signaling and regulation in cancer.
Brouwer-Visser J; Huang GS
Cytokine Growth Factor Rev; 2015 Jun; 26(3):371-7. PubMed ID: 25704323
[TBL] [Abstract][Full Text] [Related]
28. Chronic Stress Facilitates Lung Tumorigenesis by Promoting Exocytosis of IGF2 in Lung Epithelial Cells.
Jang HJ; Boo HJ; Lee HJ; Min HY; Lee HY
Cancer Res; 2016 Nov; 76(22):6607-6619. PubMed ID: 27651310
[TBL] [Abstract][Full Text] [Related]
29. Negative feedbacks in normal cell growth and their suppression in tumorigenesis.
van Staveren WC; Detours V; Dumont JE; Maenhaut C
Cell Cycle; 2006 Mar; 5(6):571-2. PubMed ID: 16582620
[No Abstract] [Full Text] [Related]
30. CmPn signaling networks in the tumorigenesis of breast cancer.
Renteria M; Belkin O; Jang D; Aickareth J; Bhalli M; Zhang J
Front Endocrinol (Lausanne); 2022; 13():1013892. PubMed ID: 36246881
[No Abstract] [Full Text] [Related]
31. MicroRNA100 inhibits self-renewal of breast cancer stem-like cells and breast tumor development.
Deng L; Shang L; Bai S; Chen J; He X; Martin-Trevino R; Chen S; Li XY; Meng X; Yu B; Wang X; Liu Y; McDermott SP; Ariazi AE; Ginestier C; Ibarra I; Ke J; Luther T; Clouthier SG; Xu L; Shan G; Song E; Yao H; Hannon GJ; Weiss SJ; Wicha MS; Liu S
Cancer Res; 2014 Nov; 74(22):6648-60. PubMed ID: 25217527
[TBL] [Abstract][Full Text] [Related]
32. miR-100 induces epithelial-mesenchymal transition but suppresses tumorigenesis, migration and invasion.
Chen D; Sun Y; Yuan Y; Han Z; Zhang P; Zhang J; You MJ; Teruya-Feldstein J; Wang M; Gupta S; Hung MC; Liang H; Ma L
PLoS Genet; 2014 Feb; 10(2):e1004177. PubMed ID: 24586203
[TBL] [Abstract][Full Text] [Related]
33. In Vitro microRNA Expression Profile Alterations under CDK4/6 Therapy in Breast Cancer.
Asberger J; Berner K; Bicker A; Metz M; Jäger M; Weiß D; Kreutz C; Juhasz-Böss I; Mayer S; Ge I; Erbes T
Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893081
[TBL] [Abstract][Full Text] [Related]
34. IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance?
Belfiore A; Rapicavoli RV; Le Moli R; Lappano R; Morrione A; De Francesco EM; Vella V
Biomedicines; 2023 Jan; 11(1):. PubMed ID: 36672737
[TBL] [Abstract][Full Text] [Related]
35. Decoding Insulin-Like Growth Factor Signaling Pathway From a Non-coding RNAs Perspective: A Step Towards Precision Oncology in Breast Cancer.
ZeinElAbdeen YA; AbdAlSeed A; Youness RA
J Mammary Gland Biol Neoplasia; 2022 Mar; 27(1):79-99. PubMed ID: 35146629
[TBL] [Abstract][Full Text] [Related]
36. The Activation of Mesenchymal Stem Cells by Glioblastoma Microvesicles Alters Their Exosomal Secretion of miR-100-5p, miR-9-5p and let-7d-5p.
Garnier D; Ratcliffe E; Briand J; Cartron PF; Oliver L; Vallette FM
Biomedicines; 2022 Jan; 10(1):. PubMed ID: 35052791
[TBL] [Abstract][Full Text] [Related]
37. Role of miR-100-5p and CDC25A in breast carcinoma cells.
Li X; Ren Y; Liu D; Yu X; Chen K
PeerJ; 2022; 9():e12263. PubMed ID: 35036112
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-100 inhibits breast cancer cell proliferation, invasion and migration by targeting FOXA1.
Xie H; Xiao R; He Y; He L; Xie C; Chen J; Hong Y
Oncol Lett; 2021 Dec; 22(6):816. PubMed ID: 34671430
[TBL] [Abstract][Full Text] [Related]
39. MACE-Seq-based coding RNA and TrueQuant-based small RNA profile in breast cancer: tumor-suppressive miRNA-1275 identified as a novel marker.
Majed SO; Mustafa SA
BMC Cancer; 2021 Apr; 21(1):473. PubMed ID: 33910530
[TBL] [Abstract][Full Text] [Related]
40. The Interplay Between Non-coding RNAs and Insulin-Like Growth Factor Signaling in the Pathogenesis of Neoplasia.
Ghafouri-Fard S; Abak A; Mohaqiq M; Shoorei H; Taheri M
Front Cell Dev Biol; 2021; 9():634512. PubMed ID: 33768092
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
